| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
Lumiliximab manufacturers
- Lumiliximab
-
- $592.00
-
2026-08-08
- CAS:357613-86-6
- Purity: > 95%
- Supply Ability: 10g
|
| | Lumiliximab Basic information |
| Product Name: | Lumiliximab | | Synonyms: | Lumiliximab;Gomiliximab;Research Grade Lumiliximab (DHC21301);Research Grade Gomiliximab (DHC21302);Lumiliximab (anti-FceR2);IDEC-152|||ST-152;Research Grade Lumiliximab | | CAS: | 357613-86-6 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Lumiliximab Structure]() |
| | Lumiliximab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Lumiliximab Usage And Synthesis |
| Uses | Lumiliximab (Anti-CD23 Recombinant Antibody) is an anti-CD23 monoclonal antibody that inhibits allergen-induced responses[1]. | | References | [1] Poole JA, et al. Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects. J Allergy Clin Immunol. 2005 Oct;116(4):780-8. DOI:10.1016/j.jaci.2005.07.007 |
| | Lumiliximab Preparation Products And Raw materials |
|